Harvest Group Wealth Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $468 | Hold |
13
| – | – | ﹤0.01% | 168 |
|
|
2022
Q4 | $579 | Hold |
13
| – | – | ﹤0.01% | 166 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 171 |
|
|
2022
Q2 | $0 | Buy |
13
+7
| +117% | – | ﹤0.01% | 185 |
|
|
2022
Q1 | $0 | Sell |
6
-4
| -40% | – | ﹤0.01% | 140 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 116 |
|